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Introduction
Toxoplasma gondii is an obligatory protozoan parasite that 
can infect virtually all warm-blooded animals (Boothroyd, 
2009; Dubey, 2010). T. gondii causes toxoplasmosis, the 
clinical signs of which include encephalitis and hepatitis, 
in immunocompromised people or the newborn babies of 
women who contracted the infection for the first time during 
pregnancy (Frenkel and Remington, 1980; Montoya and 
Remington, 2008). As humans have increased contact with 
domestic or wild animals, the number of T. gondii-infected 
animals and/or toxoplasmosis patients is expected to increase. 
In fact, we previously showed that the incidence of T. gondii-
infected wild animals is increasing (Bando et al., 2015). In 
addition, T. gondii is considered one of the most important 
human pathogens that cause economic losses and loss of life 
due to food-borne illness in the United States (Batz et al., 
2012). Thus, T. gondii is one of the most important zoonotic 
pathogens.
The host immune response plays an important role in 
antagonizing T. gondii infection. In particular, type I cytokine 
interferon-gamma (IFN-γ) is a critical host factor for anti-T. 
gondii responses in mammalian cells (Suzuki et al., 1988). 
IFN-γ-induced anti-T. gondii responses have been extensively 
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Abstract
Toxoplasma is an important intracellular pathogen that causes lethal toxoplasmosis 
in humans and animals. Interferon-γ (IFN-γ) is critical for anti-T. gondii responses 
in both humans and mice. Recent extensive studies using the mouse as a model 
organism have revealed that IFN-γ-inducible GTPases play critical roles and have 
revealed that virulent T. gondii can inhibit IFN-γ-mediated host immune responses. 
Thus, the relationship between host immunity and T. gondii virulence is well 
established in mice. In contrast, IFN-γ-induced anti-T. gondii responses in humans 
are not completely clear because the IFN-γ-inducible GTPase-mediated anti-T. gondii 
responses may not be notable in humans. Therefore, the T. gondii virulence strategy to 
resist IFN-γ-induced anti-T. gondii responses in humans also remains largely unclear. 
Here, we generated human cells lacking the IFN-γ-inducible gene, and showed that 
IDO1 is required for the IFN-γ-induced response in human cells. Then, we focused 
on T. gondii virulence mechanisms in human cells. Specifically, we focused on the 
distinct T. gondii virulence mechanisms involving TgIST and TgGRA15 to suppress 
IFN-γ-dependent immunity in human cells. We generated TgIST- or TgGRA15-
deficient T. gondii by using the CRISPR/Cas9 system, and showed that IDO1 mRNA 
induction is inhibited in a TgIST-dependent manner in IFN-γ-stimulated human 
cells. We also found that the IDO1-dependent anti-T. gondii response is inhibited in a 
TgGRA15-dependent manner in secondarily infected cells. Taken together, our data 
show that T. gondii possesses at least two differential virulence mechanisms in which 
IDO1 is targeted by TgIST and TgGRA15 to antagonize IFN-γ-induced anti-T. gondii 
responses in human cells.
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analyzed by using the mouse model. In mice, it is known that 
the accumulation of p47 immunity-related GTPases (IRGs) 
and p65 guanylate-binding proteins (GBPs) on parasitophorous 
vacuoles (PVs) of T. gondii lead to their destruction (Lee et 
al., 2015; Ma et al., 2014; MacMicking, 2012; Ohshima et al., 
2015; Taylor et al., 2007; Yamamoto et al., 2012). In contrast, 
the importance of GBPs- or IRGs-mediated mechanisms in 
humans is less certain. For example, humans have only one 
IRG, which is IFN-γ-non-inducible, whereas mice have 20 
IRGs (Bekpen et al., 2005). Thus, it remains unclear which 
host factors are important for anti-T. gondii responses in 
humans. Therefore, we performed a comprehensive analysis of 
the role of IFN-γ-inducible genes for anti-T. gondii responses 
in human cells.
T. gondii secretes various virulence factors, including 
rhoptry proteins (ROPs) and dense granule proteins (GRAs), 
into host cells to resist the IFN-γ-dependent anti-T. gondii 
host immune responses (Hakimi et al., 2017; Hunter and 
Sibley, 2012). The virulence mechanisms of parasite effector 
molecules against the host’s immune responses have been 
extensively analyzed in mouse models. (Behnke et al., 2011; 
Etheridge et al., 2014; Fentress et al., 2010; Reese et al., 2011; 
Rosowski et al., 2014; Rosowski and Saeij, 2012; Steinfeldt et 
al., 2010). However, some previous reports suggest that IFN-
γ-induced anti-T. gondii host immune responses differ between 
mouse and human cells (Ohshima et al., 2014; Selleck et al., 
2015). Therefore, we also analyzed the T. gondii virulence 
mechanisms targeting IFN-γ-dependent anti-T. gondii 
molecules in human cells.
IDO1 is required for the anti-T. gondii
response in human cells
We previously showed that Autophagy-related protein 16-1 
(ATG16L1) plays an important role in the IFN-γ-dependent 
anti-T. gondii response in mouse cells (Ohshima et al., 2014). 
Subsequently, we generated ATG16L1-deficient human cells 
by using the CRISPR/Cas9 system and analyzed the role 
of ATG16L1 in IFN-γ-dependent anti-T. gondii responses. 
Interestingly, the parasite number in IFN-γ-activated 
ATG16L1-deficient human cells was the same as that in IFN-
γ-activated wild-type human cells, suggesting an ATG16L1-
independent IFN-γ-induced anti-T. gondii response in humans. 
So, we then generated various kinds of IFN-γ-inducible gene-
deficient human cells by using the CRISPR/Cas9 system, 
and analyzed the role of the target genes in the anti-T. gondii 
responses. We found that indoleamine 2,3-dioxygenases 1 
(IDO1) was strongly induced by IFN-γ and has a critical 
role in the anti-T. gondii responses in humans. Next, we 
analyzed the molecular mechanisms of the IDO1-dependent 
anti-T. gondii responses. We observed that IDO1-dependent 
degradation of tryptophan, which is an essential amino acid for 
T. gondii intracellular growth, led to restricted parasite growth, 
but not inhibition of parasite invasion. Taken together, our 
data show that IDO1 has a critical role in the IFN-γ-dependent 
growth inhibition of T. gondii in human cells (Bando et al., 
2018b).
Toxoplasma effector TgIST directly 
suppresses IDO1 expression
IDO1 expression is STAT1 dependent (Sotero-Esteva et 
al., 2000), and a previous study demonstrated that TgIST is 
secreted from dense granules and associates with the host 
nucleosome remodeling and deacetylase complex to inhibit 
the expression of STAT1-dependent genes (Gay et al., 2016; 
Olias et al., 2016). Therefore, we hypothesized that TgIST has 
an important role in the inhibition of STAT1-mediated IDO1 
expression. To examine this possibility, we generated TgIST-
deficient T. gondii by using the CRISPR/Cas9 system, and 
tested whether TgIST deficiency affected T. gondii virulence 
in human cells. We found that although wild-type T. gondii 
infection led to a reduction in both IDO1 mRNA and protein, 
TgIST-deficient parasite infection did not. In addition, 
the number of TgIST-deficient parasites was significantly 
reduced compared to the number of wild-type parasites in 
IFN-γ-stimulated human cells, suggesting that TgIST has an 
important role in parasite growth in IFN-γ-activated human 
cells. Taken together, our findings demonstrate that TgIST 
directly suppresses the IDO1-dependent anti-T. gondii response 
by preventing STAT1 activation in human cells (Bando et al., 
2018b).
Toxoplasma effector TgGRA15 indirectly 
downregulates the IDO1-dependent anti-
parasitic response in human cells
Toxoplasma effector TgGRA15 influences the activation 
of host immune responses by inducing the host transcription 
factor NF-κB in mice (Gov et al., 2013; Jensen et al., 
2011; Rosowski et al., 2011). In addition, a previous study 
demonstrated that TgGRA15-deficient T. gondii promotes 
parasite growth in mice (Jensen et al., 2013; Rosowski et al., 
2011), suggesting that TgGRA15 supports host survival by 
inhibiting parasite growth. Thus, the significance of TgGRA15 
as a virulence factor remains unclear. Therefore, we explored 
the potential role of TgGRA15 as a virulence factor in human 
cells. During parasite infection in vivo, T. gondii preferentially 
infects CD11b+ cells, such as monocytes, and spreads into 
various organs (Courret et al., 2006). To mimic this in vivo 
cell-cell interaction in vitro using human cells, monocyte-
hepatocyte co-culture models have been developed because 
toxoplasmic hepatitis is a serious manifestation of T. gondii 
infection (Frenkel and Remington, 1980). First, we generated 
TgGRA15-deficient T. gondii by using the CRISPR/Cas9 
system, then we infected human monocytes with the T. gondii 
and seeded these infected cells on human hepatocytes with 
or without IFN-γ. Surprisingly, the TgGRA15-deficient T. 
gondii infection resulted in a significant reduction in the 
parasite numbers compared to the wild-type parasite infection 
under these monocyte-hepatocyte co-culture conditions, 
suggesting that TgGRA15 provides a growth advantage for T. 
gondii under these co-culture conditions. Next, we analyzed 
the molecular mechanisms responsible for the TgGRA15-
dependent pro-T. gondii effect. We found that TgGRA15 
induced IL-1β production in T. gondii-infected monocytes, 
which was dependent on the NLRP3 inflammasome and 
gasdermin D, and then IFN-γ and monocyte-derived IL-
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1β induced iNOS expression, which led to the inhibition of 
IDO1 expression in the hepatocytes. Taken together, our data 
demonstrate that TgGRA15 has an important role in indirectly 
downregulating the IDO1-dependent anti-T. gondii response in 
secondarily infected cells (Bando et al., 2018a).
Conclusion
In the present study, we demonstrated that IDO1 has an 
important role in IFN-γ-dependent anti-T. gondii responses in 
human cells. Further, we showed that the Toxoplasma effectors 
TgIST and TgGRA15 suppress IDO1 gene expression 
directly or indirectly to promote parasite growth in IFN-γ-
activated human cells. In addition, we recently discovered new 
virulence mechanisms of T. gondii effectors by focusing on the 
difference between the human and mouse immune responses 
(Bando et al., 2019; Fisch et al., 2019). Taken together, our 
findings could contribute to the development of a novel 
therapeutic strategy for treating human toxoplasmosis.
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